10:05am ET
Investing
8 Top Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Pfizer, Starbucks and some of the major companies reporting their quarterly results this week.
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 2:54am ET
GILD Coverage
Page 25
7:15am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
12:25pm ET
Health and Healthcare
How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs
Americans generally would like to spend less money on health care. One way that this can be and will be accomplished is through the continued use and expanded use of generic drugs.
9:55am ET
Health and Healthcare
Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains
These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.
4:04pm ET
Investing
Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club
October 13, 2016: Here are four stocks trading with relatively heavy volume among 80 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by 2 to 1…
4:04pm ET
Investing
Ericsson, Gilead Tumble Into Wednesday’s 52-Week Low Club
October 12, 2016: Here are four stocks trading with relatively heavy volume among 52 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by a slim margin…
7:10am ET
Health and Healthcare
Short Sellers Have Mixed Views on Major Biotechs
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
4:04pm ET
Investing
Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club
October 11, 2016: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in Tuesday’s session. On the NYSE, decliners led advancers by about 7Â to 1…
4:04pm ET
Investing
Gilead, Mylan Return to Friday’s 52-Week Low Club
October 7, 2016: Here are four stocks trading with relatively heavy volume among 49 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by more than 2…
4:04pm ET
Investing
Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club
October 6, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by a slight margin…
9:50am ET
Health and Healthcare
Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.
7:50am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The September 15 short interest data have been compared with the previous report, and short interest moves were upward across most of these selected biotech stocks.
12:15pm ET
Investing
4 Jefferies Stealth Stock Picks for a Very Volatile Market
We liked the list of Buy-rated stocks in a recent Jefferies research piece, as they are all good stealth plays. That is, they are top companies, under the radar, that have a…
7:05am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The August 31 short interest data have been compared with the previous report, and short interest decreased for most of these selected biotech stocks.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More
The top analyst upgrades, downgrades and initiations seen on Monday morning include Colgate-Palmolive, Gilead Sciences, Navistar, Occidental Petroleum, Pandora Media and Wal-Mart.